Screening for thrombophilia in low-risk pregnant women, newborns, and the general adult population: protocol for an evidence map

This protocol describes the methods of an evidence map addressing the following questions: Question 1. What is the volume and type of evidence on the benefits and harms of universal screening for thrombophilia in low-risk pregnant women? Question 2. What is the volume and type of evidence on the benefits and harms of universal screening for thrombophilia in newborns? Question 3. What is the volume and type of evidence on the benefits and harms of universal screening for thrombophilia in the general adult population? Data sources: MEDLINE ALL (OVID), EMBASE (OVID) and The Cochrane Library (Wiley) from 1 January 2020.